Select Publications
Conference Abstracts
, 2024, 'Abstract A067: Identifying and targeting FOLFIRINOX resistance mechanisms to improve outcomes in pancreatic cancer', in Cancer Research, American Association for Cancer Research (AACR), Vol. 84, pp. a067 - a067, http://dx.doi.org/10.1158/1538-7445.pancreatic24-a067
, 2024, 'Temporally resolved proteomics identifies nidogen-2 as a co-target in pancreatic cancer that modulates fibrosis and therapy response', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, MA, Boston, Vol. 84, presented at AACR Special Conference in Cancer Research: Advances in Pancreatic Cancer Research, MA, Boston, 15 September 2024 - 18 September 2024, http://dx.doi.org/10.1158/1538-7445.PANCREATIC24-PR-09
, 2024, 'Abstract 720: Combining zelasudil, a small molecule ROCK2 inhibitor, with chemotherapy or immunotherapy improves response in preclinical models of pancreatic cancer', in Cancer Research, American Association for Cancer Research (AACR), Vol. 84, pp. 720 - 720, http://dx.doi.org/10.1158/1538-7445.am2024-720
, 2018, 'Targeting the Hedgehog signalling pathway in triple negative breast cancer.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 36, pp. e24216 - e24216, http://dx.doi.org/10.1200/jco.2018.36.15_suppl.e24216